Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 104 Carcinoma, Hepatocellular 103 Stomach Neoplasms 62 Pancreatic Neoplasms 46 Liver Neoplasms 38 Colonic Neoplasms 37 Esophageal Neoplasms 28 Rectal Neoplasms 22 Neoplasms 13 Neoplasm Metastasis 13 Gastrointestinal Neoplasms 12 Barrett Esophagus 11 Recurrence 10 Gastrointestinal Stromal Tumors 10 Breast Neoplasms 10 Bile Duct Neoplasms 10 Pain, Postoperative 9 Lung Neoplasms 8 Cholangiocarcinoma 8 Head and Neck Neoplasms 7 Malnutrition 6 Hepatitis B 6 Carcinoma, Non-Small-Cell Lung 6 Biliary Tract Neoplasms 6 Agnosia 6 Adenocarcinoma 6 Prostatic Neoplasms 5 Postoperative Complications 5 Peptic Ulcer 5 Pain 5

Interventions

Gemcitabine 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Adenocarcinoma Pancreas × Gastrointestinal × Clear all

NCT02812992 2021-08-10

GrantPax

AIO-Studien-gGmbH

Phase 4 Completed

Gastrointestinal

Adenocarcinoma Pancreas

Data powered by HemOnc (CC BY 4.0) Colophon ⚡